[Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide].
Robak
T
T
Krykowski
E
E
Matusewicz
W
W
Brodowski
L
L
Hołub
A
A
Drzewoski
J
J
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage*; D004351:Drug Resistance; D005047:Etoposide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction
D003561:Cytarabine; D005047:Etoposide
Wyniki leczenia ostrej białaczki szpikowej opornej na konwencjonalna chemioterapie za pomoca średnio duzych dawek cytarabiny i etopozydu.